ParadigMS Symposium 2023
Register now for the eight ParadigMS Belgian Symposium!
ParadigMS Foundation invites Belgian neurologists, MS nurses and other interested professionals to mark Thursday 20th April 2023 in their agenda!
The workshops, plenary session, sponsored break-outs and panel discussions bring you new insights that improve your day-to-day clinical practice.
• As a neurologist or nurse: Get inspired by MS experts and share your own experiences, meet colleagues and discover the work of other neurologists in the field of MS.
• As a resident: Get familiar with this specific field of neurology and build a networking within Belgian MS care.
• As an non-health care practitioner: Hear the view of MS experts and connect to the Belgian MS treatment and care community.
The top 5 objectives to make your participation a success?
1. Ask your question or share a comment related to MS treatment and care
2. Meet colleagues that work on similar clinical cases
3. Get informed on some of the latest news related to MS treatment and care
4. Establish new contacts that can support your daily clinical work or research project
5. Learn from the international experience from our speakers
Register via this link
ParadigMS Belgium Symposium 2023
Thursday 20th April
Brussels Airport (Sheraton Hotel)
Fees, translation and accreditation
The Symposium is offered for free, thanks to our sponsors whom were not involved in the elaboration of the scientific programme and presentations.
All plenary sessions are simultaneously translated from English to Dutch and French.
RIZIV/INAMI accreditation will be requested for the Workshops (1 hour) and the keynotes and panel discussion (1 hour).
- Sponsored break-outs
ParadigMS Belgium Symposium 2023 – Thursday 20th April
Brussels Airport (Sheraton Hotel)
|17:30 – 18:00||Welcome coffee (onsite)|
|18:00 – 19:00||Workshop: Real-life data on switching medication (onsite) – Melinda Magyari (DK)|
|18:00 – 19:00||Workshop: Immunology and the mechanisms of immune system disfunction (onsite) – Vincent van Pesch (BE)|
|19:00 – 19:10||Welcome & Introduction (onsite & online)|
|19:10 – 19:30||Keynote and Q&A|
EBV (Epstein-Barr Virus) (onsite & online) – Niels Hellings (BE)
|19:35 – 20:05||Sponsored break-out Janssen|
(onsite & online)
|19:35 – 20:05||Sponsored break-out Roche|
(onsite & online)
|20:10 – 20:45||Networking dinner (onsite)|
|20:45 – 21:05||Keynote and Q&A|
New technologies in the neurological field (OCT, evoked potentials, remote monitoring, AI): What can I use today? And what is coming? – (onsite & online) – Letizia Leocani (IT)
|21:05 – 21:30||Q&A and panel discussion on topics of the workshops and keynotes (onsite & online)|
|21:30 – 22:15||Networking (onsite)|
|Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: www.dmsr.dk/) and a consultant neurologist at the Danish Multiple Sclerosis Center. Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved in pharmacoepidemiological studies investigating the effectiveness and long-term safety of disease modifying therapies.|
|Niels Hellings is Director of the Biomedical research Institute (BIOMED) and Professor Immunology at the Faculty of Medicine and Life Sciences of Hasselt University.|
His research is focused on immune mechanisms that limit autoimmune mediated central nervous system damage in the context of multiple sclerosis (MS). One aspect focuses on the different cues responsible for impaired immune regulation of the immune system in MS. Another part focuses on neuropoietic cytokines as mediators of CNS regeneration. To study this, a wide variety of immunological assays are applied including high speed cell sorting of immune subsets, functional in vitro assays (suppression co-cultures, cytokines (TH1,2,17), cytotoxicity assays) and multicolor flow cytometric phenotyping. BIOMED has access to well defined fresh patient samples of MS through a strong collaboration with national and international neurologists. Apart from human in vitro studies, well established experimental animal models for MS are up and running. Niels Hellings has 3 post docs, 4 predocs and 2 technicians under his guidance and published over 80 peer-reviewed papers (H-index: 23 >1900 cites). He is an expert member of the FWO Med3 commission and board member of the Belgian Immunological Society.
|Letizia Leocani is Associate professor of Neurology at Vita-Salute San Raffaele University, Neurologist in the Neurorehabilitation Unit of the Neurological Dep.t and supervisor of the Experimental neurophysiology Unit and of Magnetic IntraCerebral Stimulation (MagICSI) center – Institute of Experimental Neurology, IRCCS Ospedale San Raffaele.|
After her medical degree, she obtained a PhD in Human Physiology and Neurology specialty and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. She is Co-Chair of the Clinical Neurophysiology scientific panel of the European Academy of Neurology.
Her fields of interest involve translational validation of electrophysiological (advanced EEG analysis, evoked and cognitive potentials) and structural (optical coherence tomography – OCT) markers of diseases of the central nervous system and of treatment strategies using non invasive brain stimulation to potentiate the effects of drugs and neurorehabilitation.
|Dr Van Pesch served as neurology resident at the Department of Neurology, Saint-Luc Hospital and then progressed in positions from Adjunct Clinical Head to Associate Clinical Head and finally to Adjunct Chief of Neurology Department at the Cliniques Universitaires Saint-Luc.|
He is also responsible for the coordination and supervision of the neurophysiology unit and is consultant for the clinical biology department concerning neuro-immunological analysis. He obtained his medical degree in 1999 from the UCLouvain and then completed his PhD thesis in neuroimmunology in 2003.
At the UCLouvain, Dr Van Pesch is a Professor of Neurology and is responsible for teaching neuroimmunology and cerebrospinal fluid/neurochemistry analysis. He is the Principal investigator of the Neurochemistry Unit at the Institute of Neuroscience currently supervising 2 PhD students. Dr Van Pesch also greatly contributes to scientific publications and has over 169 published papers in a number of renowned journals. He is also co-editor of Frontiers Neurology, section of Multiple Sclerosis and neuroimmunology and section of Neuroepidemiology and has Co-editor of the Acta Neurologica Belgica between 2014 and 2022.
Can I change my registration?
Yes, you can change the selections you made in your registration. Eg.: adding or deleting a specific session.
You cannot however, change an online into an on-site ticket or visa-versa. For this, you will need to cancel your ticket and register for a new ticket.
I missed a session, can I watch it somewhere?
All plenary sessions are recorded and can be watched at this platform.
You need to create an account to access all ParadigMS learning materials.
What happens to my personal data?
ParadigMS does not sell or transfers your personal details to any third party except for the following:
1) Your first and last name are shared with our sponsors and partners. It allows them to know whom has registered and to invite those health care practitioners not yet registered. We do not share contact details (fe: email address). Should you not wish we share your first and last name with our sponsors and partners, please let us know at firstname.lastname@example.org.
2) ParadigMS uploads your details into its contact database. ParadigMS uses this database to send information on its activities. You can always unsubscribe form that mailinglist.
The general data protection policy of the organiser, can be downloaded here.
Can I cancel my registration?
Yes, you can cancel your registration. Certainly for onsite participants we very much appreciate if you let us know you cannot join – as it allows us to adjust the order for the catering in time.
What browser do we use to participate at the event?
The website is best used via Chrome or Firefox.
Terms and Conditions
The general terms and conditions of the organiser can be downloaded here.
Until when, can I register this event?
You can register onsite until 15th April and online until 20th April.
When: Thursday 20th April 2023
Onsite: Brussels Airport (Sheraton Hotel – Brussels Airport, 1930 Brussel)
Online: Via paradigms.foundation (information to connect will be shared 5 working days beforehand)
Registration fee: free, but pre-registration is mandatory
Interpretation: Live – From English to Dutch/ French
Accreditation: RIZIV/INAMI will be requested for the Workshops (1 hour) and the keynotes and panel discussion (1 hour)
How to get there?
By train: train station Brussels Airport is at walking distance and you avoid the traffic!
By car: carpark 1 at Brussels Airport is closest (and most expensive), carpark 2 and 3 are cheaper options and also at walking distance.
The topic and speakers of the sponsored break-outs will be announced as soon as they come available. Objective is to announce them the latest end February 2023.
Both Janssen and Roche will programme a sponsored-break out. These will also be live streamed.